Shanghai Xinhua hospital — Shanghai

Public research footprint of Shanghai Xinhua hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-alcoholic Fatty Liver Disease · Acute Lung Injury · Solid Tumor Cancer Treatment With Immunotherapy · Acute Respiratory Distress Syndrome (ARDS)

Recently updated registry entries

NCT03898765 — Dry Blood Spot Screening Test for Biliary Atresia（DBS-SCReBA） (Withdrawn)
NCT07584954 — Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety… (Recruiting)
NCT07129330 — RSPO3/SDC-1 Pathway Dysfunction in Alveolar Repair After ARDS in Older Adults (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Shanghai Xinhua hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.